Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeoVax Labs (GOVX) Capital Expenditures (2017 - 2025)

GeoVax Labs' Capital Expenditures history spans 13 years, with the latest figure at $10718.0 for Q2 2025.

  • Quarterly results put Capital Expenditures at $10718.0 for Q2 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $27612.0 (up 33.69% YoY), and the annual figure for FY2025 was $27612.0, up 33.69%.
  • Capital Expenditures for Q2 2025 was $10718.0 at GeoVax Labs, down from $16894.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $62186.0 in Q1 2022 to a low of $6192.0 in Q3 2023.
  • The 5-year median for Capital Expenditures is $20197.0 (2022), against an average of $25380.6.
  • The sharpest move saw Capital Expenditures surged 1025.06% in 2021, then crashed 88.06% in 2023.
  • Year by year, Capital Expenditures stood at $27789.0 in 2021, then surged by 86.67% to $51875.0 in 2022, then tumbled by 63.47% to $18949.0 in 2023, then grew by 8.99% to $20653.0 in 2024, then crashed by 48.1% to $10718.0 in 2025.
  • According to Business Quant data, Capital Expenditures over the past three periods came in at $10718.0, $16894.0, and $20653.0 for Q2 2025, Q1 2025, and Q3 2024 respectively.